HOTH
Hoth Therapeutics·NASDAQ
--
--(--)
--
--(--)
7.90 / 10
Outperform
Analyst sentiment is overwhelmingly bullish, with a 100% Strong‑Buy rating from one firm, though historical win‑rate is modest (33%). Fund‑flow metrics score 7.24, showing positive inflows across most investor sizes except large blocks. Overall sentiment favors upside, but limited analyst coverage warrants caution.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-03-25
InstitutionD. Boral Capital
Times predicted12
Historical Win Rate33.3%
What is the analyst consensus for HOTH?
- HOTH holds a Bullish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 7.90/10 (Outperform).
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
